By stabilizing p53, inhibiting the MDM2-p53 interaction, and enhancing mitochondrial-mediated apoptosis, triptolide effectively restores and amplifies p53’s tumor-suppressive functions in various cancer models. Here, TP53 is linked to neoplasm.